Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Lung Cancer Année : 2021

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

Dates et versions

hal-03689919 , version 1 (07-06-2022)

Identifiants

Citer

Nanruoyi Zhou, Maria Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene Fares, et al.. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC. Lung Cancer, 2021, 161, pp.34-41. ⟨10.1016/j.lungcan.2021.08.009⟩. ⟨hal-03689919⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More